📉 The Financial Deep Dive
S H Kelkar & Company Limited (SHK) has demonstrated a significant turnaround in profitability, reporting a consolidated profit of ₹67.4 crore for the nine months ending FY2026, a stark contrast to the ₹29.3 crore loss in the same period last year. This marks a substantial recovery, with Earnings Per Share (EPS) improving to ₹4.9 from ₹-2.1 YoY.
Performance Snapshot:
Nine Months Ended FY2026 (9M FY2026):
- Revenue from operations climbed 10.4% YoY to ₹1,718 crore (vs. ₹1,556 crore in 9M FY2025).
- EBITDA saw a 18.7% decline YoY to ₹182 crore (vs. ₹224 crore in 9M FY2025).
- Adjusted EBITDA, excluding certain costs, fell 5.1% YoY to ₹240 crore (vs. ₹253 crore in 9M FY2025).
- Adjusted EBITDA margin contracted to 14.0% from 16.4% YoY, reflecting ongoing growth investments.
Third Quarter of FY2026 (Q3 FY2026):
- Revenue from operations increased 7.5% YoY to ₹583.8 crore (vs. ₹543.2 crore in Q3 FY2025).
- EBITDA decreased 13.1% YoY to ₹56.1 crore (vs. ₹64.5 crore in Q3 FY2025).
- EBITDA margin compressed to 9.7% from 11.9% YoY.
- Consolidated net profit for Q3 FY2026 surged 86.35% YoY to ₹32.63 crore, with EPS at ₹2.36.
The "So What?" for Investors:
The company is navigating a strategic investment phase. While this has led to short-term margin pressure and a decline in reported EBITDA, the significant profit turnaround and the revenue growth indicate underlying business strength. The acquisition of the first customer order for its US Creative Development Centre is a key positive, validating its global expansion strategy. Investors must weigh the impact of these investments on near-term profitability against the potential for sustainable long-term growth and market penetration.
🚀 Risks & Outlook
Management commentary highlights a commitment to strengthening global Creative Development Centres, expanding capacity, and investing in innovation. These initiatives are geared towards the "next leg of growth." The successful securing of a customer order at the US CDC is a notable achievement, signalling early traction in a key international market.
However, the company acknowledges potential near-term increases in debt to fund these strategic initiatives. Coupled with the current margin compression, this presents a risk that investors will monitor closely. The CFO's emphasis on financial discipline, prudent capital structure, working capital efficiency, and enhanced cash conversion over the medium term suggests a balanced approach to managing these growth investments.
The long-term direction appears focused on global expansion and enhanced R&D capabilities. The ability to translate these investments into sustained profitable growth while managing leverage will be crucial for future performance.
Impact (Rating: 7/10) - The profit turnaround and US market win are significant positives, but margin pressure and acknowledged debt increase require careful investor watch.